Defence therapeutics opens u.s. laboratory in boston-cambridge biotech hub

Montreal, quebec--(newsfile corp. - june 2, 2025) -  defence therapeutics inc. (cse: dtc) (otcqb: dtcff) (fse: dtc) ("defence" or the "company"), a leading biotechnology company specializing in advanced endosomal escape technologies, is pleased to announce the opening of its first u.s. laboratory in the boston-cambridge area. this strategic expansion marks defence therapeutics' initial physical presence in the united states, reinforcing its commitment to advancing cutting-edge research and development in one of the world's foremost biotech clusters.
HUBG Ratings Summary
HUBG Quant Ranking